Maxonis

Maxonis is dedicated to providing innovative solutions for individuals affected by brain and nerve trauma. With a focus on enhancing the quality of life for patients, Maxonis offers advanced medical practices and groundbreaking treatments.

At Maxonis, the commitment to research and development is paramount. The company's flagship solution, AGRG, has undergone rigorous testing, consistently demonstrating its effectiveness in repairing nerves affected by spinal cord injuries and damage to peripheral nerves. This dedication to innovation positions Maxonis as a leader in the medical field.

Founded in 2022, Maxonis is built upon more than 15 years of dedicated research. The company's work is safeguarded by a robust patent portfolio, comprising 5 patent families, ensuring the protection and advancement of their unique medical solutions. Information regarding Maxonis's complete range of services and locations will be completed soon with the support of the company’s management.

To the manager of Maxonis, we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative work.